ArticleSignal transduction and targeted therapy2022

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants.

Hong Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.